Impax Asset Management Group plc Has $95.61 Million Holdings in Intuitive Surgical, Inc. $ISRG

Impax Asset Management Group plc increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 60.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 213,773 shares of the medical equipment provider’s stock after buying an additional 80,545 shares during the quarter. Impax Asset Management Group plc owned 0.06% of Intuitive Surgical worth $95,606,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in shares of Intuitive Surgical by 2.1% in the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after purchasing an additional 670,302 shares in the last quarter. State Street Corp lifted its holdings in Intuitive Surgical by 1.2% during the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock valued at $8,451,223,000 after purchasing an additional 182,871 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Intuitive Surgical by 1.4% during the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock valued at $4,429,590,000 after purchasing an additional 109,904 shares during the last quarter. Norges Bank acquired a new position in Intuitive Surgical in the second quarter valued at about $2,569,260,000. Finally, Invesco Ltd. grew its stake in Intuitive Surgical by 4.8% during the second quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock worth $2,402,488,000 after buying an additional 201,159 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the stock. HSBC lifted their target price on shares of Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a research note on Monday, January 26th. BTIG Research reiterated a “buy” rating and issued a $616.00 price objective on shares of Intuitive Surgical in a research report on Friday, January 23rd. UBS Group reissued a “neutral” rating on shares of Intuitive Surgical in a research note on Thursday, January 15th. Barclays set a $712.00 target price on Intuitive Surgical and gave the company an “overweight” rating in a research note on Monday, January 26th. Finally, Mizuho set a $575.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $617.23.

Intuitive Surgical Trading Up 0.5%

Shares of NASDAQ:ISRG opened at $495.15 on Wednesday. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $609.08. The stock has a market capitalization of $175.84 billion, a P/E ratio of 62.76, a P/E/G ratio of 3.83 and a beta of 1.65. The business has a 50-day moving average price of $546.68 and a two-hundred day moving average price of $510.62.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter in the previous year, the company earned $2.21 EPS. Intuitive Surgical’s revenue was up 18.8% on a year-over-year basis. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Myriam Curet sold 126 shares of Intuitive Surgical stock in a transaction on Thursday, January 29th. The stock was sold at an average price of $520.02, for a total transaction of $65,522.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Mark Brosius sold 464 shares of the stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $548.49, for a total value of $254,499.36. Following the completion of the transaction, the senior vice president directly owned 131 shares in the company, valued at $71,852.19. The trade was a 77.98% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 55,530 shares of company stock worth $30,459,295. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.